National Malaria Control Program, Vietnam Report issue

Government

Organization Overview

First Clinical Trial
2013
NCT01872702
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (3)

dihydroartemisinin (1 trial)

piperaquine (1 trial)

primaquine (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 3